None
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Participants who have been successfully enrolled in the bioequivalence trials of Progesterone Sustained-release vaginal gel; 2)Have signed the informed consent form, have a full understanding of the content, process, and risks of this study, and can communicate well with the researchers.
Exclusion criteria
Exclusion criteria: Participants who may not be able to complete the study for other reasons or are deemed by the investigator to be unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body composition;Blood pharmacokinetic parameters (Tmax, T1/2, Cmax, AUC0-t, AUC0-8);Safety;Pharmacokinetic parameters (Tmax T1/2 AUC0-t); | — |
Countries
China
Contacts
The Second Affiliated Hospital of Wenzhou Medical University